1-3 of 3
Wai Yiu
Close
Sort by
Journal Articles

Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial

Herve Avet-Loiseau, Cyrille Hulin, Lofti Benboubker, Meletios A. Dimopoulos, Andrew Belch, Donna Reece, John Catalano, Antonio Pinto, Heinz Ludwig, Nizar J Bahlis, Michele Cavo, Michel Attal, Philippe Moreau, Lugui Qiu, Richard LeBlanc, Rik Schots, S. Vincent Rajkumar, Jennifer Marek, Guang Chen, Wai Yiu, Annette Ervin-Haynes, Thierry Facon
Journal: Blood
Blood (2015) 126 (23): 730.
https://doi.org/10.1182/blood.V126.23.730.730
Published: 2015
Journal Articles

Continuous Treatment with Lenalidomide and Low-Dose Dexamethasone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma in Asia: Subanalysis of the First Trial

Jin Lu, Jae Hoon Lee, Shang-Yi Huang, Lugui Qiu, Je-Jung Lee, Ting Liu, Sung-Soo Yoon, Kihyun Kim, Zhi Xiang Shen, HyeonSeok Eom, Wenming Chen, Chang-Ki Min, Hyo Jung Kim, Jeong Ok Lee, Jae Yong Kwak, Wai Yiu, Guang Chen, Annette Ervin Haynes, Cyrille Hulin, Thierry Facon
Journal: Blood
Blood (2015) 126 (23): 4240.
https://doi.org/10.1182/blood.V126.23.4240.4240
Published: 2015
Journal Articles

Overview of Venous Thromboembolism (VTE) in Nearly 100,000 Patients Treated with Revlimid® (lenalidomide).

Lilia Weiss, MD, Kamal Shah, MD, Wai Yiu, PharmD, John Freeman, MSc., BSc., LLB, DipClinSci., Robert Knight, MD, Jerome B. Zeldis, MD
Journal: Blood
Blood (2009) 114 (22): 2881.
https://doi.org/10.1182/blood.V114.22.2881.2881
Published: 2009